IP Library Granted Patent US 8,911,798
Granted Patent B2
US 8,911,798 · App. 12/212,391 · Granted Dec 16, 2014

Multivitamin and mineral compositions for individuals having renal disease

Inventor: Ajay Gupta (Henderson, NV)
A23L1/302A23L1/304A23L1/3051A23V2002/00Y10S514/904Y10S514/905
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,798
App. No.
12/212,391
Granted
Dec 16, 2014
Kind
B2
Abstract

The present invention relates to oral compositions which are useful for nutrient supplementation. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of patients in various stages of chronic kidney disease and supplementing levels of physiological anti-oxidants, vitamins, and minerals in subjects requiring dialysis therapy.

Claims (14)

1. A nutrient composition for treating nutritional deficiencies in an individual or patient in need thereof, comprising an oral dosage form including carotenoids, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 9 , vitamin B 12 , selenium, zinc, L-cysteine, and glutathione, said composition being free of vitamin A and salts and/or esters of vitamin A.

2. The nutrient composition of claim 1 , wherein said composition is substantially free of other vitamins and minerals.

3. The composition of claim 1 , comprising 450-600 mcg carotenoids, 60-100 mg vitamin C, 400-1200 IU vitamin D, 30 IU vitamin E, 25-50 mcg vitamin K, 1-2 mg vitamin B 1 , 1-2 mg vitamin B 2 , 10-30 mg vitamin B 3 , 5-10 mg vitamin B 5 , 5-10 mg vitamin B 6 , 150-300 mcg vitamin B 7 , 1-2 mg vitamin B 9 , 10-25 mcg vitamin B 12 , 15-30 mcg selenium, 5-10 mg zinc, 15-25 mg L-cysteine, and 15-25 mg glutathione.

4. The composition of claim 1 , comprising 500 mcg carotenoids, 80 mg vitamin C, 800 IU vitamin D, 30 IU vitamin E, 25 mcg to 50 mcg vitamin K, 1.2 mg vitamin B 1 , 1.25 mg vitamin B 2 , 15 mg vitamin B 3 , 7.5 mg vitamin B 5 , 15 mg vitamin B 6 , 200 mcg vitamin B 7 , 1.2 mg vitamin B 9 , 18 mcg of vitamin B 12 , 20 mcg of selenium, 7.5 mg zinc, 20 mg of L-cysteine, and 20 mg of glutathione.

5. The composition of claim 1 , wherein said composition is in a powder, caplet, tablet, lozenge, pill, capsule, or liquid dosage form.

6. The composition of claim 1 , wherein said composition further comprises a pharmaceutically acceptable carrier.

7. A method for supplementing nutrients in a subject having nutritional deficiencies comprising the step of administering to said subject a composition in oral dosage form comprising 450-600 mcg carotenoids, 60-100 mg vitamin C, 400-800 IU vitamin D, 30 IU vitamin E, 25-50 mcg vitamin K, 1-2 mg vitamin B 1 , 1-2 mg vitamin B 2 , 10-30 mg vitamin B 3 , 5-10 mg vitamin B 5 , 5-10 mg vitamin B 6 , 150-300 mcg vitamin B 7 , 1-2 mg vitamin B 9 , 10-25 mcg vitamin B 12 , 15-30 mcg selenium, 5-10 mg zinc, 15-25 mg L-cysteine, and 15-25 mg glutathione, said composition being free of vitamin A and salts and/or esters of vitamin A.

8. The method of claim 7 , wherein said composition comprises 500 mcg carotenoids, 80 mg vitamin C, 800 IU vitamin D, 30 IU vitamin E, 25 mcg or 50 mcg vitamin K, 1.2 mg vitamin B 1 , 1.25 mg vitamin B 2 , 15 mg vitamin B 3 , 7.5 mg vitamin B 5 , 15 mg vitamin B 6 , 200 mcg vitamin B 7 , 1.2 mg vitamin B 9 , 18 mcg of vitamin B 12 , 20 mcg of selenium, 7.5 mg zinc, 20 mg of L-cysteine, and 20 mg of glutathione.

9. The method of claim 7 , wherein said composition is substantially free of other vitamins and minerals.

10. The method of claim 7 , wherein said composition is administered to said individual or patient daily.

11. The method of claim 7 , wherein said composition further comprises a pharmaceutically acceptable carrier.

12. The method of claim 7 , wherein said composition is administered to an individual suffering from kidney disease.

13. The method of claim 7 , wherein said composition is administered to an individual having Stage IV or V kidney disease.

14. The method of claim 7 , wherein said composition is administered to an individual undergoing dialysis therapy.

Continuity (2)
Provisional Application 60972935 · Sep 17, 2007
Related Publication 20090074883A1 · Mar 19, 2009